Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Hubbard

Showing results (281-290 of 363) with videos related to

Pageof 37
Sort By:
The American Journal of Gastroenterology|August 5, 2000
Reduced risk of upper gastrointestinal ulcer complications with celecoxib, a novel COX-2 inhibitorJ L Goldstein, F E Silverstein, N M Agrawal, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 9, 2011
Metabolic cross-talk allows labeling of O-linked beta-N-acetylglucosamine-modified proteins via the N-acetylgalactosamine salvage pathwayMichael Boyce, Isaac S Carrico, Anjali S Ganguli, et al.
The Journal of Clinical Investigation|June 1, 1991
Expression of the secretory leukoprotease inhibitor gene in epithelial cellsT Abe, N Kobayashi, K Yoshimura, et al.
The American Review of Respiratory Disease|July 1, 1991
Immediate and late inflammatory responses to ragweed antigen challenge of the peripheral airways in allergic asthmatics. Cellular, mediator, and permeability changesM C Liu, W C Hubbard, D Proud, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|December 17, 2008
Treatment of osteoarthritis with a once-daily dosing regimen of celecoxib: a randomized, controlled trialG W Williams, R E Ettlinger, E M Ruderman, et al.
Arthritis and Rheumatism|September 29, 1998
Preliminary study of the safety and efficacy of SC-58635, a novel cyclooxygenase 2 inhibitor: efficacy and safety in two placebo-controlled trials in osteoarthritis and rheumatoid arthritis, and studies of gastrointestinal and platelet effectsL S Simon, F L Lanza, P E Lipsky, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|November 1, 1990
Aerosolization of recombinant SLPI to augment antineutrophil elastase protection of pulmonary epitheliumC Vogelmeier, R Buhl, R F Hoyt, et al.
Journal of the American Dental Association (1939)|October 13, 2025
High-risk medications in pediatric dentistry: Patterns, outcomes, and clinical implicationsYilei Liu, Kawtar Zouaidi, Colin C Hubbard, et al.
Digestive Diseases and Sciences|March 25, 1998
Prostaglandin levels in human colorectal mucosa: effects of sulindac in patients with familial adenomatous polyposisF M Giardiello, E W Spannhake, R N DuBois, et al.
The American Review of Respiratory Disease|July 1, 1990
Evidence for elevated levels of histamine, prostaglandin D2, and other bronchoconstricting prostaglandins in the airways of subjects with mild asthmaM C Liu, E R Bleecker, L M Lichtenstein, et al.
Pageof 37

Showing results (281-290 of 363) with videos related to

Sort By:
Pageof 37
The American Journal of Gastroenterology|August 5, 2000
Reduced risk of upper gastrointestinal ulcer complications with celecoxib, a novel COX-2 inhibitorJ L Goldstein, F E Silverstein, N M Agrawal, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 9, 2011
Metabolic cross-talk allows labeling of O-linked beta-N-acetylglucosamine-modified proteins via the N-acetylgalactosamine salvage pathwayMichael Boyce, Isaac S Carrico, Anjali S Ganguli, et al.
The Journal of Clinical Investigation|June 1, 1991
Expression of the secretory leukoprotease inhibitor gene in epithelial cellsT Abe, N Kobayashi, K Yoshimura, et al.
The American Review of Respiratory Disease|July 1, 1991
Immediate and late inflammatory responses to ragweed antigen challenge of the peripheral airways in allergic asthmatics. Cellular, mediator, and permeability changesM C Liu, W C Hubbard, D Proud, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|December 17, 2008
Treatment of osteoarthritis with a once-daily dosing regimen of celecoxib: a randomized, controlled trialG W Williams, R E Ettlinger, E M Ruderman, et al.
Arthritis and Rheumatism|September 29, 1998
Preliminary study of the safety and efficacy of SC-58635, a novel cyclooxygenase 2 inhibitor: efficacy and safety in two placebo-controlled trials in osteoarthritis and rheumatoid arthritis, and studies of gastrointestinal and platelet effectsL S Simon, F L Lanza, P E Lipsky, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|November 1, 1990
Aerosolization of recombinant SLPI to augment antineutrophil elastase protection of pulmonary epitheliumC Vogelmeier, R Buhl, R F Hoyt, et al.
Journal of the American Dental Association (1939)|October 13, 2025
High-risk medications in pediatric dentistry: Patterns, outcomes, and clinical implicationsYilei Liu, Kawtar Zouaidi, Colin C Hubbard, et al.
Digestive Diseases and Sciences|March 25, 1998
Prostaglandin levels in human colorectal mucosa: effects of sulindac in patients with familial adenomatous polyposisF M Giardiello, E W Spannhake, R N DuBois, et al.
The American Review of Respiratory Disease|July 1, 1990
Evidence for elevated levels of histamine, prostaglandin D2, and other bronchoconstricting prostaglandins in the airways of subjects with mild asthmaM C Liu, E R Bleecker, L M Lichtenstein, et al.
Pageof 37